Follow Us 
The Story of Adar Poonawalla, India's Vaccine Prince
Don’t Miss Out on the Latest Updates.
Subscribe to Our Newsletter Today!
Covishield
Covishield News
Benefits Of Covishield COVID Vaccine Far Outweigh Extremely Rare Potential Side Effects: AstraZeneca
India.com News Desk May 1, 2024 1:01 AM IST
AstraZeneca, following global outrage over the side effects of the vaccine, said on Tuesday that the benefits of the vaccine "far outweigh" the risks of "extremely rare" potential side effects.
AstraZeneca Admits of Rare Side Effects by Covishield; Here is What Happens When Blood Clots Inside Your Body
India.com Lifestyle Staff April 30, 2024 11:41 AM IST
AstraZeneca, the Covid vaccine manufacturer has admitted that covishield might have rare side effects leading to blood clot thrombosis.
Bharat Biotech's Nasal Vaccine Can Be Given As Booster Dose | Complete Details Inside
Tahir Qureshi December 24, 2022 3:58 PM IST
To fight the Coronavirus, the government has included Bharat Biotech's nasal vaccine in the vaccination program as a booster dose.
Bombay HC Issues Notice To Bill Gates, Serum Institute, DGCI, Others Over Plea On Alleged 'Vaccine Death'
India.com News Desk September 2, 2022 11:35 PM IST
Bill Gates, Serum Institute of India (SII), Drug Controller of India (DGCI) and other were sent notices by the Bombay High Court to respond to a plea filed by a man over his daughter's alleged 'vaccine death'.
Fully Vaccinated Adults Can Take Corbevax as Booster Shot 6 Months After Second Dose, Centre Issues Guidelines
India.com News Desk August 10, 2022 9:06 PM IST
Earlier in the day, the Central government Corbevax as a heterologous precaution dose for adults above 18 years for restricted use with two doses of either Covishield or Covaxin.
Biological E's Corbevax Approved as Booster for Those Jabbed with Covishield, Covaxin
India.com News Desk August 10, 2022 11:27 AM IST
For the first time, the union government has approved a booster dose that is different from the one used for primary vaccination against Covid has been allowed in the country.
Covishield Found Ineffective Against Omicron, Booster Required: NIV Study
India.com News Desk April 24, 2022 5:34 PM IST
Those who have taken the Covishield vaccine with no history of COVID had the lowest neutralising power against BA.1 variant of Omicron, a study by the Indian Council of Medical Research-National Institute of Virology (ICMR-NIV), Pune stated.
Omicron, Delta, Omicron: NIV Pune Reports 3-Time Covid Infection in Person Vaccinated With Covishield
India.com News Desk April 24, 2022 3:56 PM IST
The researchers in the report said that the case represented a breakthrough infection post primary SARS-CoV-2 infection and two doses of Covishield vaccination.
Delhi to Provide Free Booster Doses Soon, Prepares Hospitals As COVID Cases Rise
India.com News Desk April 15, 2022 9:30 PM IST
Those who have completed nine months after the second shot are eligible for the booster dose.
Made In India COVID-19 Vaccines Better Than Pfizer, Moderna: Adar Poonawalla
India.com News Desk April 13, 2022 4:05 PM IST
It's good that vaccines like Pfizer and Moderna are not introduced in India, because in countries like US people have taken the second and third booster dose and still many are getting infected with Corona but in India, our vaccines have given good protection," said Adar Poonawalla.
To Make It Accessible To Everyone: Adar Poonawalla on Reducing COVISHIELD Price to Rs 225
India.com News Desk April 12, 2022 6:26 PM IST
COVID Vaccine Latest Update: Saying that the SII has a stockpile of 200 million doses, Adar Poonawala said the firm has already exported 40 million doses to European countries and Australia.
Govt Caps Service Charge For COVID-19 Booster Dose Administration At Private Vaccination Centres. Check Rates HERE
India.com News Desk April 9, 2022 5:06 PM IST
The government clarified that healthcare workers, frontline workers and citizens aged 60 years or more, will continue to receive precaution dose vaccination at any CVC, including free of charge vaccination at government vaccination centres.
Covishield Vaccine Price Revised For Private Hospitals, Check Latest Rate Here
India.com News Desk April 9, 2022 3:38 PM IST
On Friday, the company had said that the precaution dose of its Covishield vaccine against COVID-19 will be priced at Rs 600 per shot for eligible individuals.
After Serum Institute, Bharat Biotech Reduces Covaxin Price to Rs 225 For Private Hospitals
India.com News Desk April 9, 2022 4:02 PM IST
We have decided to revise the price of Covaxin from Rs 1200 to Rs 225 per dose for private hospitals, Suchitra Ella, Joint Managing Director, Bharat Biotech said.
COVID Booster Dose For All Adults: Who is Eligible, How to Book Appointment, Cost of Precaution Dose | FAQs Answered
India.com News Desk April 8, 2022 9:50 PM IST
Unlike the booster shots announced for healthcare workers, frontline staff and those above 60, the third jab will not be free for most adults.
Covishield Booster to Cost Rs 600 With Taxes, Says Poonawala As Govt Allows Precaution Doses For Adults
India.com News Desk April 8, 2022 5:51 PM IST
Giving details, Adar Poonawala said the Serum Institute will offer large discounts to hospitals and distributors who like to offer booster doses.
Bharat Biotech Temporarily Slows Down COVAXIN Production. Check Here's why
India.com News Desk April 1, 2022 10:26 PM IST
In a statement, Bharat Biotech said that for the coming period, the company will focus on pending facility maintenance, process and facility optimization activities.
Reduce Covishield Dose Gap To 8-16 Weeks From 12-16: NTAGI Recommends To Govt
India.com News Desk March 20, 2022 4:26 PM IST
The government had on May 13, 2021, extended the gap between the first and second doses of the Covishield vaccine from 6-8 weeks to 12-16 weeks based on the recommendations by NTAGI.
Net Worth $26 Billion, Vaccine King Cyrus Poonawalla Is World's Richest Healthcare Billionaire
India.com Business Desk March 16, 2022 6:26 PM IST
Cyrus Poonawalla Net Worth: The 'Vaccine King' registered a growth of 41 per cent in this net worth in 2021 and is the fourth richest individual in India. Cyrus Poonawalla's net worth, at present, is $26 billion.
Maharashtra Man Claims Daughter Died of COVID Vaccine Side Effects, Seeks Rs 1000 Core Compensation
PTI February 1, 2022 10:25 PM IST
Lunawat's plea claimed the Union government's AEFI committee on October 2, 2021 admitted the death of his daughter was due to side effects of Covishield vaccine.
Bedridden For 5 Yrs, Man Starts Walking, Speaking After Covishield Dose; Doctors Say 'Miraculous Recovery'
India.com News Desk January 14, 2022 9:16 AM IST
After receiving the first dose of Covishield the anti-COVID vaccine, he not only stood up and started walking, but could also speak, much to the astonishment of his family.
Lancet Study Stating Protection Offered By Covishield Declines After 3 Months Is Misquoted: Experts
ANI December 23, 2021 9:02 PM IST
The Lancet study which reportedly stated that the protection offered by the Oxford AstraZeneca COVID vaccine Covishield declines after 3 months has been misquoted, experts said.
WHO Approves Novavax Jab As 10th Authorised Covid Vaccine
India.com News Desk December 21, 2021 10:57 PM IST
WHO said Nuvaxovid was around 90 per cent effective at reducing symptomatic cases of COVID-19 in two major clinical studies.
Bharat Biotech Seeks Phase 3 Trial For Intranasal Covid Vaccine Booster, Submits Application to DCGI
India.com News Desk December 20, 2021 5:51 PM IST
The development comes as India has detected over 160 new cases of the emergent Omicron variant of the coronavirus.
Subscribe Now
Enroll for our free updates